Ann: Trading Halt, page-303

The new Abbott test is different to the CDY test.

Abbott has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes.

https://www.abbott.com/corpnewsroom/product-and-innovation/detect-covid-19-in-as-little-as-5-minutes.html

Provides molecular results in less than 15 minutes, allowing you to make effective clinical decisions sooner. Abbott ID NOW is a rapid, instrument-based system for the qualitative detection of infectious diseases using isothermal nucleic acid amplification technology.